PGD1 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
PGD1 antibody; HRS1 antibody; MED3 antibody; YGL025CMediator of RNA polymerase II transcription subunit 3 antibody; Hyper-recombination suppressor protein 1 antibody; Mediator complex subunit 3 antibody; Poly-glutamine domain protein 1 antibody
Target Names
PGD1
Uniprot No.

Target Background

Function
The PGD1 antibody targets the PGD1 protein, a component of the Mediator complex. This complex acts as a coactivator in the regulated transcription of almost all RNA polymerase II-dependent genes. Mediator functions as a bridge, transmitting information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. In its free form, the Mediator complex adopts a compact conformation. It is recruited to promoters through direct interactions with regulatory proteins, facilitating the assembly of a functional preinitiation complex alongside RNA polymerase II and the general transcription factors. Upon recruitment, the Mediator complex unfolds to an extended conformation and partially surrounds RNA polymerase II, specifically interacting with the unphosphorylated form of the C-terminal domain (CTD) of RNA polymerase II. As transcriptional elongation begins, the Mediator complex dissociates from the RNA polymerase II holoenzyme, remaining at the promoter. PGD1/MED3 is also implicated in direct repeat recombination.
Gene References Into Functions
  1. The Med3 component of the Mediator tail module is crucial for transcription activation. Its function is suppressed by the kinase activity of the Cdk8 module. PMID: 24550274
  2. Research indicates that Nhp6p and Med3p regulate gene expression by controlling the local subunit composition of RNA polymerase II. PMID: 18448120
Database Links

KEGG: sce:YGL025C

STRING: 4932.YGL025C

Protein Families
Mediator complex subunit 3 family
Subcellular Location
Nucleus.

Q&A

What is PGD1 and why is it important in membrane biology research?

PGD1 functions as a galactoglycerolipid lipase that plays critical roles in thylakoid lipid remodeling, maintenance of thylakoid architecture, and cellular tolerance to environmental stresses. Research has demonstrated that PGD1 preferentially releases the sn-1 acyl groups of MGDG (monogalactosyldiacylglycerol), a key lipid component of thylakoid membranes . The importance of PGD1 becomes particularly evident when examining pgd1 mutants, which exhibit significant alterations in membrane lipid composition, especially under nitrogen deprivation conditions. These mutants show a reduced ability to adjust their thylakoid membrane lipid composition, particularly MGDG content, in response to nitrogen stress . Understanding PGD1 function provides critical insights into membrane dynamics during environmental adaptation in photosynthetic organisms.

What are the key considerations for selecting appropriate PGD1 antibodies?

When selecting PGD1 antibodies for research, consider:

  • Antibody specificity: Choose antibodies with verified specificity through proper validation against positive controls (tissues/cells known to express PGD1) and negative controls (tissues/cells where PGD1 is absent) .

  • Antibody format: Depending on your application, either monoclonal or polyclonal antibodies may be preferable. Monoclonal antibodies offer high specificity for a single epitope, while polyclonal antibodies recognize multiple epitopes and potentially provide stronger signals but with higher background risk.

  • Validated applications: Select antibodies that have been validated for your specific application (Western blotting, immunofluorescence, flow cytometry, etc.).

  • Species reactivity: Ensure the antibody recognizes PGD1 from your organism of interest. This is especially important as PGD1 has been extensively studied in Chlamydomonas but may have structural differences across species .

  • Epitope location: Consider whether the antibody recognizes regions that remain accessible in your experimental conditions, particularly for membrane-associated proteins like PGD1.

How should researchers validate PGD1 antibodies before use in critical experiments?

Proper validation requires a systematic approach:

  • Multiple positive and negative controls: Always use several positive controls (tissues/cells known to express PGD1) and negative controls (tissues/cells lacking PGD1 expression) simultaneously . For instance, if studying PGD1 in Chlamydomonas, wild-type strains like dw15-1 can serve as positive controls, while pgd1 mutant strains provide excellent negative controls .

  • Complementary methods: Confirm PGD1 expression using multiple assays. For example, if using immunoblotting, complement with RT-PCR or mass spectrometry to confirm protein identity .

  • Cell line validation: Cell lines endogenously expressing or lacking PGD1 can be valuable for initial validation, though tissue samples remain essential for comprehensive validation and assessment of non-specific binding .

  • mRNA expression correlation: When protein expression data is unavailable, cells or tissues with known PGD1 mRNA expression patterns can guide validation efforts .

  • Knockout/knockdown verification: If available, PGD1 knockout or knockdown systems provide definitive negative controls, similar to the pgd1 mutant described in the literature .

What are the most effective techniques for detecting PGD1 in membrane fractions?

The membrane-associated nature of PGD1 requires specialized approaches:

  • Subcellular fractionation: Isolate chloroplasts and further separate thylakoid membranes before antibody-based detection. This enriches the target protein and reduces background.

  • Western blotting optimization: When detecting PGD1 in membrane fractions:

    • Use gentle detergents (0.5-1% Triton X-100 or n-dodecyl β-D-maltoside) for membrane solubilization

    • Transfer proteins using lower methanol concentrations to improve transfer efficiency of hydrophobic proteins

    • Longer blocking times (2+ hours) may reduce non-specific binding

    • Consider wet transfer systems rather than semi-dry for better transfer of membrane proteins

  • Immunofluorescence microscopy: For localizing PGD1 within cellular compartments, permeabilization conditions must be carefully optimized to access membrane-embedded epitopes without disrupting membrane structures.

  • Proximity labeling techniques: Methods like BioID or APEX can be combined with PGD1 antibodies to identify proximal proteins and understand PGD1's interaction network within membranes.

How can researchers design experiments to study PGD1's role in stress response using antibodies?

Based on known PGD1 functions in stress response, design experiments that:

  • Compare stress conditions: Examine PGD1 expression and localization under multiple stress conditions, as PGD1 expression changes in response to nitrogen deprivation, cold, high salt, and high osmoticum . Design your experimental timeline based on these findings:

    • Nitrogen deprivation: 72-96 hours

    • Cold stress: 48-96 hours

    • High salt stress: 24-48 hours

    • High osmoticum: 24-96 hours

  • Track temporal changes: Conduct time-course experiments to monitor PGD1 expression changes during stress adaptation. The table below summarizes recommended sampling times based on published data:

    Stress ConditionEarly ResponseMid ResponseLate Response
    N deprivation24h72h96h
    Cold stress24h48h96h
    High salt24h48h72h
    High osmoticum24h48h96h
  • Correlate with physiological measures: Combine antibody detection of PGD1 with measurements of:

    • ROS-sensitive fluorescence using H₂DCFDA

    • Chlorophyll content

    • Lipid peroxidation (TBARS)

    • Membrane lipid composition analysis

  • Use mutant and complemented lines: Compare wild-type, pgd1 mutant, and complemented lines (like G3 and G4) to establish causality between PGD1 function and stress phenotypes .

What protocols enable accurate quantification of PGD1 expression levels?

For accurate quantification:

  • Western blot quantification:

    • Use housekeeping proteins appropriate for your experimental conditions

    • Include a standard curve of recombinant PGD1 (if available)

    • Employ fluorescent secondary antibodies rather than chemiluminescence for wider linear range

    • Analyze using software like ImageJ with background subtraction

  • ELISA-based quantification:

    • Develop sandwich ELISA using two antibodies recognizing different PGD1 epitopes

    • Include standard curves with known PGD1 concentrations

    • Validate by spike-in recovery experiments

  • Flow cytometry for cellular quantification:

    • Permeabilize cells appropriately for intracellular staining

    • Use fluorescence minus one (FMO) controls

    • Calibrate with quantitative beads to establish molecule number per cell

  • Normalization strategies:

    • Always normalize to total protein when comparing across stress conditions

    • Consider using multiple reference proteins when studying stress conditions that may affect typical housekeeping genes

How can researchers address non-specific binding issues with PGD1 antibodies?

Non-specific binding is a common challenge that can be addressed through:

  • Optimization of blocking conditions:

    • Test different blocking agents (BSA, milk, commercial blockers)

    • Extend blocking time to 2+ hours at room temperature or overnight at 4°C

    • Consider adding 0.1-0.3% Triton X-100 to blocking buffer for membrane proteins

  • Antibody dilution optimization:

    • Perform dilution series to identify optimal antibody concentration

    • For polyclonal antibodies against PGD, concentrations around 0.05 mg/ml have been reported

  • Pre-absorption with negative control lysates:

    • Pre-incubate antibody with lysates from cells lacking PGD1 (e.g., pgd1 mutant)

    • Remove non-specific antibodies through centrifugation before using in experiments

  • Cross-reactivity assessment:

    • Test antibody against related proteins to evaluate potential cross-reactivity

    • For PGD1, this might include testing against other lipases with similar structure

  • Alternative detection methods:

    • Compare results using different secondary antibodies or detection systems

    • Consider monoclonal antibodies for higher specificity if polyclonal antibodies show high background

What factors might affect the reproducibility of experiments using PGD1 antibodies?

Several factors can influence reproducibility:

  • Antibody lot-to-lot variation:

    • Record lot numbers and test new lots against previous ones

    • Maintain reference samples for comparison between experiments

  • Sample preparation consistency:

    • Standardize harvest conditions, particularly important for stress experiments

    • Use consistent cell lysis protocols, especially critical for membrane proteins

    • Maintain consistent protein concentration across experiments

  • Experimental conditions:

    • Control temperature strictly during membrane protein experiments

    • Standardize incubation times and washing steps

    • Use calibrated equipment for all measurements

  • Physiological state of experimental organisms:

    • Maintain consistent growth conditions for control samples

    • Document culture density and growth phase

    • For Chlamydomonas studies, ensure consistent light cycles and media composition

  • Data analysis consistency:

    • Use the same software settings for quantification

    • Apply consistent background subtraction methods

    • Employ the same statistical tests across studies

How should researchers interpret contradictory results between different antibody-based methods when studying PGD1?

When faced with contradictory results:

  • Methodological hierarchy assessment:

    • Evaluate methodological strengths for your specific research question

    • For membrane proteins like PGD1, consider which method best preserves native membrane structure

  • Technical validation approach:

    • Verify antibody binding using recombinant PGD1 if available

    • Confirm results with knockout/knockdown controls

    • Consider epitope accessibility in different techniques

  • Orthogonal validation strategy:

    • Supplement antibody-based methods with non-antibody approaches

    • For PGD1, consider activity assays measuring lipase function

    • Genetic complementation can verify functional relevance

  • Condition-specific expression analysis:

    • Determine if contradictions reflect genuine biological differences under various conditions

    • For PGD1, expression and localization may change substantially under stress conditions

  • Resolution through structural biology:

    • Consider if different antibodies recognize distinct conformational states

    • For membrane proteins, detergent solubilization may affect epitope accessibility

How can PGD1 antibodies be utilized to investigate membrane remodeling during environmental stress?

PGD1 antibodies enable sophisticated studies of membrane dynamics:

  • Co-localization with membrane markers:

    • Use PGD1 antibodies alongside markers for different membrane domains

    • Track changes in localization patterns during stress responses

    • Quantify co-localization coefficients before and during stress exposure

  • Fractionation-based approaches:

    • Isolate membrane microdomains using detergent-resistant membrane preparation

    • Track PGD1 redistribution between fractions during stress

    • Correlate with changes in lipid composition

  • In situ proximity labeling:

    • Combine with proximity labeling approaches to identify stress-specific interaction partners

    • Map PGD1's changing interaction network under conditions like nitrogen deprivation

  • Correlative microscopy:

    • Combine immunofluorescence with electron microscopy to relate PGD1 localization to ultrastructural changes

    • Particularly relevant given PGD1's role in thylakoid architecture

  • Super-resolution microscopy:

    • Apply techniques like STORM or PALM with PGD1 antibodies

    • Resolve nanoscale changes in membrane organization during stress

What approaches enable researchers to study the relationship between PGD1 activity and ROS accumulation?

Given PGD1's connection to ROS metabolism during stress :

  • Dual fluorescence imaging:

    • Combine immunofluorescence detection of PGD1 with ROS-sensitive dyes like H₂DCFDA

    • Perform co-localization analysis to determine spatial relationships

  • Temporal correlation analysis:

    • Track PGD1 expression levels and ROS accumulation in time-course experiments

    • Establish sequence of events during stress response

  • Subcellular fractionation with ROS measurements:

    • Isolate chloroplasts and measure compartment-specific ROS levels

    • Correlate with PGD1 abundance in the same fractions

  • Genetic complementation studies:

    • Use PGD1 antibodies to verify expression levels in complementation lines

    • Correlate expression levels with ROS measurements and stress tolerance

  • Pharmacological approaches:

    • Combine with ROS scavengers or inducers

    • Determine if ROS modulation affects PGD1 expression or localization

The data in the table below, derived from published research, illustrates the relationship between PGD1 function and stress-induced ROS accumulation:

ConditionROS in PL dw15-1 (Control)ROS in pgd1 MutantTBARS in PL dw15-1TBARS in pgd1 Mutant
TAP-N96Moderate (cytosolic)High (chloroplastic)LowHigh
TBP-N96Low (cytosolic)Low (cytosolic)LowLow

This data demonstrates that PGD1 deficiency leads to chloroplast-specific ROS accumulation and lipid peroxidation only under certain stress conditions (TAP-N96), highlighting the context-dependent nature of PGD1's protective role .

How can researchers use PGD1 antibodies to investigate its interaction with lipid metabolism pathways?

To explore PGD1's role in lipid metabolism:

  • Co-immunoprecipitation studies:

    • Use PGD1 antibodies to pull down protein complexes

    • Identify interaction partners through mass spectrometry

    • Focus on associations with other lipid metabolism enzymes

  • Metabolic labeling experiments:

    • Track lipid synthesis using labeled precursors

    • Correlate with PGD1 expression and localization

    • Compare wild-type and pgd1 mutant patterns

  • Lipid droplet association studies:

    • Investigate PGD1's potential association with lipid droplets during stress

    • Particularly relevant given PGD1's involvement in TAG accumulation during N deprivation

  • In vitro activity assays:

    • Immunoprecipitate PGD1 using specific antibodies

    • Measure lipase activity on various substrates

    • Correlate with in vivo lipid remodeling patterns

  • Lipidomic correlation analysis:

    • Quantify membrane lipid species and PGD1 levels across stress conditions

    • Identify statistical associations between specific lipid changes and PGD1 abundance

Research has shown that PGD1 preferentially releases sn-1 acyl groups from MGDG, with subsequent implications for TAG synthesis under nitrogen deprivation. The acyl composition at both the sn-1 and sn-2 positions shows subtle but consistent differences in pgd1 mutants compared to controls .

How might next-generation PGD1 antibodies enhance our understanding of membrane dynamics?

Future antibody technologies could provide new insights:

  • Conformation-specific antibodies:

    • Develop antibodies recognizing active vs. inactive PGD1 conformations

    • Enable tracking of functional status during stress responses

  • Phosphorylation-specific antibodies:

    • Generate antibodies against specific post-translational modifications

    • Investigate regulatory mechanisms controlling PGD1 activity

  • Single-domain antibodies (nanobodies):

    • Develop smaller antibody formats with better membrane penetration

    • Enable live-cell imaging of PGD1 dynamics

  • Bispecific antibodies:

    • Create antibodies simultaneously targeting PGD1 and interaction partners

    • Investigate complex formation under various conditions

  • Intrabodies:

    • Express antibody fragments intracellularly to track or modulate PGD1 function

    • Provide complementary approach to genetic knockouts

What are promising directions for comparative studies of PGD1 across different photosynthetic organisms?

Comparative approaches could reveal evolutionary insights:

  • Cross-species antibody validation:

    • Test PGD1 antibodies against homologs from diverse photosynthetic organisms

    • Identify conserved epitopes across evolutionary distance

  • Functional conservation analysis:

    • Compare PGD1 expression patterns during similar stresses across species

    • Determine if stress response mechanisms are conserved

  • Structural biology integration:

    • Use antibodies as tools for structural studies (e.g., cryo-EM)

    • Compare structural features of PGD1 across species

  • Ecological adaptation correlation:

    • Study PGD1 expression in organisms from different ecological niches

    • Determine if PGD1 function correlates with specific environmental adaptations

  • Synthetic biology approaches:

    • Utilize antibodies to validate heterologous expression of PGD1 variants

    • Test complementation across species boundaries

How can integrating PGD1 antibody studies with systems biology approaches advance membrane research?

Systems-level integration offers new perspectives:

  • Multi-omics correlation:

    • Correlate quantitative PGD1 protein data with transcriptomics, metabolomics, and lipidomics

    • Build predictive models of membrane remodeling during stress

  • Network analysis:

    • Place PGD1 within protein-protein interaction networks

    • Identify key nodes connecting membrane remodeling to stress signaling

  • Mathematical modeling:

    • Develop quantitative models of membrane dynamics incorporating PGD1 activity

    • Test predictions experimentally using antibody-based measurements

  • Machine learning applications:

    • Train algorithms to recognize patterns in PGD1 localization during stress

    • Identify previously unrecognized relationships between membrane organization and stress adaptation

  • Single-cell approaches:

    • Apply PGD1 antibodies in single-cell protein analysis

    • Investigate cell-to-cell heterogeneity in stress responses

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.